Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis

MacInnis, 2006, Body size and composition and prostate cancer risk: systematic review and meta-regression analysis, Cancer Causes Control, 17, 989, 10.1007/s10552-006-0049-z Littman, 2007, Anthropometrics and prostate cancer risk, Am J Epidemiol, 165, 1271, 10.1093/aje/kwm013 Rodriguez, 2007, Body mass index, weight change, and risk of prostate cancer in the Cancer Prevention Study II Nutrition Cohort, Cancer Epidemiol Biomarkers Prev, 16, 63, 10.1158/1055-9965.EPI-06-0754 Wright, 2007, Prospective study of adiposity and weight change in relation to prostate cancer incidence and mortality, Cancer, 109, 675, 10.1002/cncr.22443 Giovannucci, 2007, Risk factors for prostate cancer incidence and progression in the health professionals follow-up study, Int J Cancer, 121, 1571, 10.1002/ijc.22788 Amling, 2004, Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomy, J Clin Oncol, 22, 439, 10.1200/JCO.2004.03.132 Bassett, 2005, Impact of obesity on prostate cancer recurrence after radical prostatectomy: data from CaPSURE, Urology, 66, 1060, 10.1016/j.urology.2005.05.040 Freedland, 2004, Impact of obesity on biochemical control after radical prostatectomy for clinically localized prostate cancer: a report by the Shared Equal Access Regional Cancer Hospital database study group, J Clin Oncol, 22, 446, 10.1200/JCO.2004.04.181 Mallah, 2005, Body mass index is weakly associated with, and not a helpful predictor of, disease progression in men with clinically localized prostate carcinoma treated with radical prostatectomy, Cancer, 103, 2030, 10.1002/cncr.20991 Strom, 2005, Obesity, weight gain, and risk of biochemical failure among prostate cancer patients following prostatectomy, Clin Cancer Res, 11, 6889, 10.1158/1078-0432.CCR-04-1977 Efstathiou, 2007, Obesity and mortality in men with locally advanced prostate cancer: analysis of RTOG 85-31, Cancer, 110, 2691, 10.1002/cncr.23093 Strom, 2006, Influence of obesity on biochemical and clinical failure after external-beam radiotherapy for localized prostate cancer, Cancer, 107, 631, 10.1002/cncr.22025 Stroup, 2007, Cancer, 110, 1003, 10.1002/cncr.22873 Chun, 2007, Body mass index does not improve the ability to predict biochemical recurrence after radical prostatectomy, Eur J Cancer, 43, 375, 10.1016/j.ejca.2006.08.037 Gallina, 2007, Obesity does not predispose to more aggressive prostate cancer either at biopsy or radical prostatectomy in European men, Int J Cancer, 121, 791, 10.1002/ijc.22730 Merrick, 2007, Obesity is not predictive of overall survival following permanent prostate brachytherapy, Am J Clin Oncol, 30, 588, 10.1097/COC.0b013e318068b506 Palma, 2007, Obesity as a predictor of biochemical recurrence and survival after radiation therapy for prostate cancer, BJU Int, 100, 315, 10.1111/j.1464-410X.2007.06897.x Siddiqui, 2006, Obesity and survival after radical prostatectomy: a 10-year prospective cohort study, Cancer, 107, 521, 10.1002/cncr.22030 Gong, 2007, Obesity is associated with increased risks of prostate cancer metastasis and death after initial cancer diagnosis in middle-aged men, Cancer, 109, 1192, 10.1002/cncr.22534 Freedland, 2006, Are findings from studies of obesity and prostate cancer really in conflict?, Cancer Causes Control, 17, 5, 10.1007/s10552-005-0378-3 Venkateswaran, 2007, Association of diet-induced hyperinsulinemia with accelerated growth of prostate cancer (LNCaP) xenografts, J Natl Cancer Inst, 99, 1793, 10.1093/jnci/djm231 Cox, 2008, Insulin receptor expression by human prostate cancers, Prostate Little, 2008, Standardization of C-peptide measurements, Clin Chem, 54, 1023, 10.1373/clinchem.2007.101287 1989, Steering Committee of the Physicians' Health Study Research Group, N Engl J Med, 321, 129 Andersen, 1993 Cheng, 1998, Prediction of cumulative incidence function under the proportional hazards model, Biometrics, 54, 219, 10.2307/2534009 Banez, 2007, Obesity-related plasma hemodilution and PSA concentration among men with prostate cancer, JAMA, 298, 2275, 10.1001/jama.298.19.2275 Frasca, 2008, The role of insulin receptors and IGF-I receptors in cancer and other diseases, Arch Physiol Biochem, 114, 23, 10.1080/13813450801969715 Hsing, 2001, Prostate cancer risk and serum levels of insulin and leptin: a population-based study, J Natl Cancer Inst, 93, 783, 10.1093/jnci/93.10.783 Lehrer, 2002, Serum insulin level, disease stage, prostate specific antigen (PSA) and Gleason score in prostate cancer, Br J Cancer, 87, 726, 10.1038/sj.bjc.6600526 Hammarsten, 2005, Hyperinsulinaemia: a prospective risk factor for lethal clinical prostate cancer, Eur J Cancer, 41, 2887, 10.1016/j.ejca.2005.09.003 Keating, 2006, Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer, J Clin Oncol, 24, 4448, 10.1200/JCO.2006.06.2497 Basaria, 2006, Hyperglycemia and insulin resistance in men with prostate carcinoma who receive androgen-deprivation therapy, Cancer, 106, 581, 10.1002/cncr.21642 Chen, 2005, Prostate carcinoma incidence in relation to prediagnostic circulating levels of insulin-like growth factor I, insulin-like growth factor binding protein 3, and insulin, Cancer, 103, 76, 10.1002/cncr.20727 Stocks, 2007, Insulin resistance is inversely related to prostate cancer: a prospective study in Northern Sweden, Int J Cancer, 120, 2678, 10.1002/ijc.22587 Ma, 2004, A prospective study of plasma C-peptide and colorectal cancer risk in men, J Natl Cancer Inst, 96, 546, 10.1093/jnci/djh082 Steeg, 2006, Tumor metastasis: mechanistic insights and clinical challenges, Nat Med, 12, 895, 10.1038/nm1469 Li, 2006, Trends in hyperinsulinemia among nondiabetic adults in the US, Diabetes Care, 29, 2396, 10.2337/dc06-0289 Shaw, 2005, The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin, Science, 310, 1642, 10.1126/science.1120781